English  |  正體中文  |  简体中文  |  0  
???header.visitor??? :  53124539    ???header.onlineuser??? :  691
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"gow c h"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 1-10 of 104  (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2022-08-19T00:21:10Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang P.-C.; Chang G.-C.; CHIUN HSU; Gow C.-H.; Yang C.-H.; Shih J.-Y.; Chen K.-C.; Yu C.-J.; Yang T.-Y.; Lin C.-P.; Su W.-P.
臺大學術典藏 2022-06-27T07:07:54Z First- or second-line therapy with gefitinib produces equal survival in non-small cell lung cancer Wu J.-Y.; CHONG-JEN YU; Yang C.-H.; Wu S.-G.; Chiu Y.-H.; Gow C.-H.; Chang Y.-C.; Hsu Y.-C.; Wei P.-F.; Shih J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:54Z Frequent epidermal growth factor receptor gene mutations in malignant pleural effusion of lung adenocarcinoma Wu S.-G.; Gow C.-H.; CHONG-JEN YU; Chang Y.-L.; Yang C.-H.; Hsu Y.-C.; Shih J.-Y.; Lee Y.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:07:51Z Comparison of epidermal growth factor receptor mutations between primary and corresponding metastatic tumors in tyrosine kinase inhibitor-naive non-small-cell lung cancer Gow C.-H.; Chang Y.-L.; Hsu Y.-C.; Tsai M.-F.; Wu C.-T.; CHONG-JEN YU; Yang C.-H.; Lee Y.-C.; Yang P.-C.; Shih J.-Y.
臺大學術典藏 2022-06-27T07:06:37Z Acquired gefitinib-resistant mutation of EGFR in a chemonaive lung adenocarcinoma harboring gefitinib-sensitive mutation L858R Gow C.-H.; Shih J.-Y.; Chang Y.-L.; CHONG-JEN YU
臺大學術典藏 2022-06-27T07:06:35Z Epidermal growth factor receptor mutations in needle biopsy/aspiration samples predict response to gefitinib therapy and survival of patients with advanced nonsmall cell lung cancer Shih J.-Y.; Gow C.-H.; CHONG-JEN YU; Yang C.-H.; Chang Y.-L.; Tsai M.-F.; Hsu Y.-C.; Chen K.-Y.; Su W.-P.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:33Z Survival outcome and predictors of gefitinib antitumor activity in East Asian chemonaive patients with advanced nonsmall cell lung cancer Yang C.-H.; Shih J.-Y.; Chen K.-C.; CHONG-JEN YU; Yang T.-Y.; Lin C.-P.; Su W.-P.; Gow C.-H.; Hsu C.; Chang G.-C.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:28Z Radiotherapy in lung adenocarcinoma with brain metastases: Effects of activating epidermal growth factor receptor mutations on clinical response Gow C.-H.; Chien C.-R.; Chang Y.-L.; Chiu Y.-H.; Kuo S.-H.; Shih J.-Y.; Chang Y.-C.; CHONG-JEN YU; Yang C.-H.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:21Z Lung cancer with epidermal growth factor receptor exon 20 mutations is associated with poor gefitinib treatment response Wu J.-Y.; Wu S.-G.; Yang C.-H.; Gow C.-H.; Chang Y.-L.; CHONG-JEN YU; Shin J.-Y.; Yang P.-C.
臺大學術典藏 2022-06-27T07:06:21Z Clinical response of gefitinib on malignant pleural effusions in patients with non-small cell lung cancer Chen C.-H.; Gow C.-H.; CHONG-JEN YU; Shih J.-Y.; Hsu Y.-C.; Lee W.-Y.; Yang P.-C.; Kuo S.-H.

Showing items 1-10 of 104  (11 Page(s) Totally)
1 2 3 4 5 6 7 8 9 10 > >>
View [10|25|50] records per page